Free Trial

Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Up 254.9% in July

Lonza Group logo with Medical background

Key Points

  • Short interest in Lonza Group AG increased significantly by 254.9% in July, reaching a total of 29,100 shares.
  • The company's stock price is trading around $69.65, with a 12 month low of $55.57 and a high of $73.29.
  • Lonza Group recently increased its dividend to $0.1054 per share, marking a rise from the previous amount of $0.10.
  • Looking to export and analyze Lonza Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Lonza Group Ag (OTCMKTS:LZAGY - Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 29,100 shares, agrowthof254.9% from the June 30th total of 8,200 shares. Based on an average trading volume of 175,100 shares, the days-to-cover ratio is currently 0.2 days. Based on an average trading volume of 175,100 shares, the days-to-cover ratio is currently 0.2 days.

Lonza Group Trading Up 0.4%

Shares of OTCMKTS LZAGY traded up $0.25 during midday trading on Thursday, reaching $67.68. 2,549 shares of the company's stock were exchanged, compared to its average volume of 83,456. The company has a quick ratio of 1.04, a current ratio of 1.52 and a debt-to-equity ratio of 0.45. Lonza Group has a 52-week low of $55.57 and a 52-week high of $73.29. The business's fifty day moving average price is $70.02 and its two-hundred day moving average price is $67.09.

Lonza Group Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, May 30th. Shareholders of record on Thursday, May 15th were issued a dividend of $0.1054 per share. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a yield of 15.0%. This is an increase from Lonza Group's previous dividend of $0.10.

About Lonza Group

(Get Free Report)

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

Featured Stories

Should You Invest $1,000 in Lonza Group Right Now?

Before you consider Lonza Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lonza Group wasn't on the list.

While Lonza Group currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines